Moleculin Biotech (MBRX) Reports Q3 Loss of $0.12/Share

Moleculin Biotech (NASDAQ: MBRX) reported Q3 EPS of ($0.12), versus ($0.05) reported last year.

For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• CoStar Group acquires Zonda for $800M, adding new home data
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance